* |
If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** |
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) |
These securities are exercisable immediately. |
(2) |
These securities do not have an expiration date. |
(3) |
The Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
(4) |
Does not include shares of Common Stock that may be issued to the Reporting Person if the conditional dividend of shares of Common Stock declared by the Issuer's Board of Directors on September 8, 2005 is distributed upon the closing of the Issuer's initial public offering (the "IPO") in the event the price per share of the Issuer's Common Stock sold in the IPO is $11.40 or greater (the "Conditional Dividend"). |
(5) |
Upon consummation of the IPO, every 3 shares of Series B Preferred Stock will be converted into 1 share of Common Stock. This conversion rate is reflected in the amount of securities underlying the derivative security reported in column 3. |
(6) |
1,267,747 shares of which 1,232,973 shares are directly held by Kleiner Perkins Caufield & Byers X-A, L.P. ("KPCB X-A") and 34,774 shares are directly held by Kleiner Perkins Caufield & Byers X-B, L.P. ("KPCB X-B"). KPCB X Associates, LLC ("Associates") is the general partner of KPCB X-A and KPCB X-B. Associates disclaims beneficial ownership of the shares held directly by KPCB X-A and KPCB X-B. |
(7) |
Does not include shares of Common Stock that will be issued to the Reporting Person upon consummation of the Issuer's IPO as a result of either (a) the distribution of the Conditional Dividend or (b) the Increased Conversion Rate (as defined in footnote 8 below). |
(8) |
Upon consummation of the IPO, every 3 shares of Series E Preferred Stock will be converted into 1 share of Common Stock; provided, however, if the price per share of shares sold in the IPO is less than $11.40, the conversion rate will be 1.128 shares of Common Stock for every 3 shares of Series E Preferred Stock (the "Increased Conversion Rate"). The 1-for-3 conversion rate is reflected in the amount of securities underlying the derivative security reported in column 3. |
(9) |
332,671 shares of which 323,546 shares are directly held by KPCB X-A and 9,125 shares are directly held by KPCB X-B. Associates is the general partner of KPCB X-A and KPCB X-B. Associates disclaims beneficial ownership of the shares held directly by KPCB X-A and KPCB X-B. |
(10) |
Excludes 541,428 shares held in the name of "KPCB Holdings, Inc. as nominee" for the account of certain persons (the "Principals"). KPCB Holdings, Inc., which is affiliated with Associates, has no voting, dispositive or pecuniary interest in any of the shares that it holds. Pursuant to separate nominee agreements among KPCB Holdings, Inc. and each of the Principals, Associates was given revocable powers to vote and make investment decisions with respect to the shares covered by the nominee agreements for such Principal. However, Associates' powers on behalf of the Principals with respect to the shares held under the nominee agreements are being terminated effectively immediately upon commencement of the public offering, and accordingly are excluded from this Form 3. |
(11) |
Excludes 136,829 shares held in the name of "KPCB Holdings, Inc. as nominee" for the account of certain persons (the "Principals"). KPCB Holdings, Inc., which is affiliated with Associates, has no voting, dispositive or pecuniary interest in any of the shares that it holds. Pursuant to separate nominee agreements among KPCB Holdings, Inc. and each of the Principals, Associates was given revocable powers to vote and make investment decisions with respect to the shares covered by the nominee agreements for such Principal. However, Associates' powers on behalf of the Principals with respect to the shares held under the nominee agreements are being terminated effectively immediately upon commencement of the public offering, and accordingly are excluded from this Form 3. |